A Trusted Data Source for Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:
Also, what is 51 + 7?

New Build Report: Pharmaceutical-Biotech Sector Plans 205 New Facilities with $18.5 Billion in Capital Investment Potential

New Build Report: Pharmaceutical-Biotech Sector Plans 205 New Facilities with $18.5 Billion in Capital Investment Potential

SUGAR LAND--October 8, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Scattered throughout North America are 205 reported new-facility builds in the Pharmaceutical-Biotech Industry, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites represent a potential total capital investment of $18.5 billion, which translates to a per-site average of about $90 million. The "potential" investment for each site includes initial construction, as well as any reported planned future expansions and subsequent phases.

Within this article: Details on key new-build projects in the Pharmaceutical-Biotech Industry, including those from major companies such as Novo Nordisk AS (NYSE:NVO) and Procter & Gamble (NYSE:PG).

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)